SEC Form 4 · accession 0001209191-16-099601
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Vaughn
Officer — Chief Commercial Officer
Period of report
Feb 15, 2016
Accepted (ET)
Feb 17, 2016 · 8:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2016 | F | 3,371 | $26.53 | D | 20,705 | D | |
| Common StockF2,F3 | Feb 16, 2016 | A | 10,550 | $0.00 | A | 31,255 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) HoldingF4 | $27.00 | Feb 16, 2016 | A | 61,700 | A | — | Feb 16, 2026 | Common Stock | 61,700 | 61,700 | D |
Explanation of responses
- F1Includes an aggregate of 7,730 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F2Restricted stock units awarded on February 16, 2016 which vest as to 1/3 of the shares on each of February 15, 2017, 2018 and 2019.
- F3Includes an aggregate of 18,280 shares of common stock issuable pursuant to restricted stock units that have not vested.
- F4The option becomes exercisable as to 25% of the shares on February 16, 2017, and becomes exercisable as to 1/48th of the shares each full month thereafter.